Chinese english Germany Japanese Korea

1-(2-Fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine

1-(2-Fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine Struktur
1415793-99-5
CAS-Nr.
1415793-99-5
Englisch Name:
1-(2-Fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine
Synonyma:
3-Fluoro-4-(piperazin-1-yl)phenylboronic acid pinacol ester;1-(2-Fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine;Piperazine, 1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-
CBNumber:
CB72550221
Summenformel:
C16H24BFN2O2
Molgewicht:
306.18
MOL-Datei:
1415793-99-5.mol
Request For Quotation

1-(2-Fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine Eigenschaften

Sicherheit

1-(2-Fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine Chemische Eigenschaften,Einsatz,Produktion Methoden

1-(2-Fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-(2-Fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alchem Pharmtech,Inc. 		8485655694
sales@alchempharmtech.com United States 63711 58
ShangHai Wisacheam Pharmaceutical Co., Ltd. 13817485796
 tim@wisacheampharm.com China 3737 58
Combiphos (Shanghai) Biological Technology Co., Ltd. 021-65232103 17602124823
 combiphos@vip.qq.com China 20005 58
Jinan Xinhongtai Chemical Co. LTD 13000000000
 jnxinhongtai@126.com China 19528 58
Hebei Int'en Pharmaceutical Technology Co., Ltd 18932921510
 jyxia@int-nph.com China 2084 58
  • 1-(2-Fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine
  • 3-Fluoro-4-(piperazin-1-yl)phenylboronic acid pinacol ester
  • Piperazine, 1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-
  • 1415793-99-5
  • C16H24BFN2O2
Copyright 2019 © ChemicalBook. All rights reserved